32
BIOTECHNOLOGY VALUE FUND L P updates its Form D — $1.51B sold
Fund raise update · Hedge fund · Open-ended · Offering Indefinite · Sold $1.51B · SAN FRANCISCO, CA · filed 2024-12-27
32
BIOTECHNOLOGY VALUE FUND L P updates its Form D — $1.55B sold
Fund raise update · Hedge fund · Open-ended · SAN FRANCISCO, CA · Form D/A filed 2025-12-23 · all Biotechnology Value vehicles
$100M+ sold
Why now — by persona
Relevant to: Fund audit & tax, Fund administrator. Lead card pending.
People on the filing
| James N. Kratky | Chief Financial Officer, Chief Compliance Officer |
| Jason N. McCune | Chief Operating Officer |
| Mark N. Lampert | Chief Executive Officer |
| n/a N. BVF I GP LLC | General Partner |
| n/a BVF Inc. | Executive Officer |
| n/a N. BVF GP Holdings LLC | Executive Officer |
| n/a BVF Partners, L.P. | Investment Manager |
Signed by Mark N. Lampert, Chief Executive Officer of the General Partner.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.